Panacea Biotec is currently trading at Rs. 168.45, up by 4.80 points or 2.93% from its previous closing of Rs. 163.65 on the BSE.
The scrip opened at Rs. 161.00 and has touched a high and low of Rs. 175.80 and Rs. 161.00 respectively. So far 14267 shares were traded on the counter.
The BSE group 'B' stock of face value Rs. 1 has touched a 52 week high of Rs. 199.00 on 27-Jun-2014 and a 52 week low of Rs. 82.30 on 19-Aug-2013.
Last one week high and low of the scrip stood at Rs. 175.80 and Rs. 161.00 respectively. The current market cap of the company is Rs. 1036.98 crore.
The promoters holding in the company stood at 74.81% while Institutions and Non-Institutions held 2.25% and 22.94% respectively.
Panacea Biotec has received an approval to raise funds by way of issue of equity shares and/or other securities, etc. aggregating up to Rs 250 crore or equivalent thereof in any currency, subject to approval of the shareholders. The board of directors at its meeting held on August 01, 2014 has approved for the same.
Panacea Biotec is one of India’s leading research based health management companies with established research, manufacturing and marketing capabilities.
Company Name | CMP |
---|---|
Sun Pharma Inds. | 1530.00 |
Dr. Reddys Lab | 5913.95 |
Cipla | 1421.00 |
Zydus Lifesciences | 993.40 |
Lupin | 1684.00 |
View more.. |